10x Your Lab: High Content Analysis Meets High-Throughput Screening | |||||
Tue4 Oct02:30pm(5 mins)
|
![]() |
Ms Kristin Halfpenny | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Accelerating Drug Discovery with Cell Painting | |||||
Tue4 Oct12:10pm(30 mins)
|
![]() |
Mr James Pilling | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Advancing UK Medicines Discovery through Innovative Partnerships | |||||
Wed5 Oct04:15pm(30 mins)
|
![]() |
Dr Martin Main | |||
Session : Innovation through partnership - Sponsored by AstraZeneca Open Innovation | |||||
Room: Auditorium 2 |
An Educational Approach for Drug Discover Using AI Driven Closed Loop Experimentation | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
Dr Joshua Kangas | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour | |||||
Tue4 Oct02:40pm(30 mins)
|
![]() |
Dr Romain Lara | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Assist Plus Pipetting Platform | |||||
Tue4 Oct02:30pm(5 mins)
|
![]() |
Ms Sharon Barnard | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Audience Lead Panel Discussion with Q&A | |||||
Tue4 Oct04:30pm(30 mins)
|
![]() |
Dr Allan Jordan |
![]() |
Sarah Skerrat | |
Session : Overcoming Challenges and New Directions in Medicinal Chemistry | |||||
Room: Auditorium 2 |
Automated analysis workflow to identify metal contamination in HTS outputs | |||||
Wed5 Oct11:35am(30 mins)
|
![]() |
Dr Rachel Moore | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™ | |||||
Tue4 Oct12:40pm(5 mins)
|
![]() |
James Curtis | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Beyond Small Molecules… | |||||
Wed5 Oct12:35pm(15 mins)
|
![]() |
David Madge | |||
Session : Innovation through partnership - Sponsored by AstraZeneca Open Innovation | |||||
Room: Auditorium 2 |
Bioluminescent assay tools for TCR-T and CAR-T development and characterisation | |||||
Tue4 Oct02:35pm(5 mins)
|
![]() |
Dr Craig Malcolm | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Biomarker Discovery Using Preclinical Models: Resources, Challenges and Opportunities | |||||
Wed5 Oct11:05am(30 mins)
|
![]() |
![]() |
Dr Benjamin Haibe-Kains | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Collaborative AMR Implementation in Biopharmaceutical Labs | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
Mr Thomas Albanetti | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Cost Effective Decapping | |||||
Wed5 Oct02:35pm(5 mins)
|
![]() |
Mr Adam McGinnis | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Dementia Drugs through Partnership at the ALBORADA Drug Discovery Institute | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
Dr John Skidmore | |||
Session : Innovation through partnership - Sponsored by AstraZeneca Open Innovation | |||||
Room: Auditorium 2 |
Discovery of the clinical candidate, ASTX029, a dual mechanism ERK inhibitor | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
Dr Nicola Wallis | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Early Career Professional Introduction | |||||
Wed5 Oct09:50am(5 mins)
|
![]() |
Dr Mark Soave | |||
Session : ELRIG - Early Career Professional Impact Award - Supported by Elemental Machines | |||||
Room: Auditorium 1 |
Early experimental medicine studies for investigating new drugs for COPD | |||||
Tue4 Oct03:45pm(30 mins)
|
![]() |
Prof Dave Singh | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Efficient low-priced custom automation at Abbvie | |||||
Wed5 Oct11:05am(30 mins)
|
![]() |
Mario Richter | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
From HTS Campaign to Biophysical Characterization: The Art of Generating Promising Hit Series for PIM3 Kinase | |||||
Wed5 Oct02:35pm(5 mins)
|
![]() |
![]() |
Dr Celine Legros | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Generating improved preclinical models for profiling novel combinations | |||||
Wed5 Oct03:45pm(30 mins)
|
![]() |
![]() |
Ms Elizabeth Hardaker | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
High Content Imaging as an enabling tool for early drug discovery | |||||
Tue4 Oct11:10am(30 mins)
|
![]() |
Dr John Bassett | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Image-based drug screening in patient biopsies for personalized systems medicine and drug discovery | |||||
Wed5 Oct04:15pm(30 mins)
|
![]() |
![]() |
Prof Berend Snijder | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
iPSC automation platform | |||||
Wed5 Oct12:05pm(30 mins)
|
![]() |
Dr Martine Geraerts | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Life beyond the pixels: single-cell analysis using deep learning and image analysis methods | |||||
Tue4 Oct02:40pm(30 mins)
|
![]() |
Dr Peter Horvath | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Ligand discovery in dark chemical space leading to biological insights | |||||
Wed5 Oct12:05pm(30 mins)
|
![]() |
Dr John Irwin | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Magnetic Electrospun Microfibre Scaffold Assemblies: Examples of there use for Cell-Based Screening Applications | |||||
Tue4 Oct04:15pm(15 mins)
|
![]() |
Gary Allenby | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Methods to tackle novel molecular targets involved in inflammatory disease | |||||
Tue4 Oct04:15pm(15 mins)
|
![]() |
Dr Mark Abbott | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Microplate readers and imaging systems | |||||
Tue4 Oct12:40pm(5 mins)
|
![]() |
Imran Haneef | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
ML/AI: Opportunities, Impact and Future Directions in Drug Design | |||||
Tue4 Oct12:10pm(30 mins)
|
![]() |
Sarah Skerrat | |||
Session : Overcoming Challenges and New Directions in Medicinal Chemistry | |||||
Room: Auditorium 2 |
Multiparametric drug discovery facilitated by automated liquid handling | |||||
Wed5 Oct12:35pm(15 mins)
|
![]() |
Mark Graham | |||
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
New perspectives for modelling inflammatory diseases using patient-derived organoids | |||||
Tue4 Oct12:10pm(5 mins)
|
![]() |
Dr Sylvia F. Boj | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
New technologies for the design and characterisation of nanotechnology mediated therapeutics | |||||
Tue4 Oct09:35am(45 mins)
|
|
Prof Molly Stevens | |||
Session : Keynote Presentation | |||||
Room: Auditorium 1 |
New/Novel/Ground-breaking technologies assisting the sustainable preclinical drug discovery | |||||
Wed5 Oct02:30pm(5 mins)
|
![]() |
![]() |
Dr Karthi Rajamani | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Next Generation Platforms for Human Gene Therapy | |||||
Tue4 Oct04:30pm(30 mins)
|
![]() |
Prof Aravind Asokan | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Novel drug targets in COPD | |||||
Tue4 Oct11:40am(30 mins)
|
![]() |
Prof Ian Adcock | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Organoid Biobanks for Cancer Drug Discovery | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
![]() |
Dr Mathew Garnett | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Oxford Nanopore Technologies - a look into the complete genome | |||||
Wed5 Oct12:35pm(15 mins)
|
![]() |
Mr Daniel Fordham | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Pandemic response: accessible BSL3 platforms for drug discovery | |||||
Wed5 Oct09:55am(20 mins)
|
![]() |
![]() |
Dr Shaun Pennington | ||
Session : ELRIG - Early Career Professional Impact Award - Supported by Elemental Machines | |||||
Room: Auditorium 1 |
Phenonaut; a tool for multiomic data integration, analysis, prediction, and inference | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Dr Steven Shave | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Dr Michael Anbar | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Platforms for the generation and high-throughput screening of cyclic peptide libraries. | |||||
Wed5 Oct11:05am(30 mins)
|
![]() |
Prof Ali Tavassoli | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Preclinical translational models for investigating drugs for the treatment of COPD | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Dr Simon Pitchford | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Pressure over liquid – Established technology but with new value | |||||
Wed5 Oct02:30pm(5 mins)
|
![]() |
Paul Kendall | |||
Session : Innovation through partnership - Sponsored by AstraZeneca Open Innovation | |||||
Room: Auditorium 2 |
Publishing in the British Journal of Pharmacology | |||||
Tue4 Oct04:30pm(30 mins)
|
![]() |
Mr Charles Whalley | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Quantitative high-throughput screening of single cancer cell phenotypes in 3D matrices | |||||
Tue4 Oct04:30pm(30 mins)
|
![]() |
Ms Vicky Bousgouni | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Session Introduction | |||||
Wed5 Oct11:00am(5 mins)
|
![]() |
Dr Lisa Mohamet |
![]() |
Dr Samantha Barichievy | |
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Session Introduction | |||||
Tue4 Oct11:05am(5 mins)
|
![]() |
Dr Allan Jordan |
![]() |
Sarah Skerrat | |
Session : Overcoming Challenges and New Directions in Medicinal Chemistry | |||||
Room: Auditorium 2 |
Session Introduction | |||||
Tue4 Oct11:05am(5 mins)
|
![]() |
Ms Sian Lewis |
![]() |
Dr Michael Howell | |
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Session Introduction | |||||
Wed5 Oct11:00am(5 mins)
|
![]() |
Dr Kathryn Chapman |
![]() |
David Powell | |
Session : Innovation through partnership - Sponsored by AstraZeneca Open Innovation | |||||
Room: Auditorium 2 |
Session Introduction | |||||
Tue4 Oct11:05am(5 mins)
|
![]() |
Chris Herring |
![]() |
Claire Dobson | |
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Session Introduction | |||||
Wed5 Oct11:00am(5 mins)
|
![]() |
Martin Swarbrick |
![]() |
Dr Mary Wheldon | |
![]() |
Prof A Ganesan |
![]() |
Mrs Becky Garton | ||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
Session Introduction | |||||
Tue4 Oct11:05am(5 mins)
|
![]() |
Dr Anna Morgan |
![]() |
Dr Simon Pitchford | |
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Session Introduction | |||||
Wed5 Oct11:00am(5 mins)
|
![]() |
Mario Richter |
|
Kirsten Tschapalda | |
Session : Advancements in Screening and Automation Sponsored by IDBS | |||||
Room: Auditorium 3 |
Simplifying Synthesis with Electricity | |||||
Wed5 Oct04:15pm(45 mins)
|
![]() |
Prof Phil Baran | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
spheroONE – an automated high throughput spheroid isolation and manipulation technology. | |||||
Tue4 Oct02:35pm(5 mins)
|
![]() |
Alice Cheesbrough | |||
Session : High Content Imaging in Drug Discovery | |||||
Room: Auditorium 1 |
Supporting innovations in Splicesome research | |||||
Tue4 Oct02:30pm(5 mins)
|
![]() |
Mrs ROSLYN McConnell | |||
Session : Overcoming Challenges and New Directions in Medicinal Chemistry | |||||
Room: Auditorium 2 |
Targeting the template: A novel therapeutic strategy for prion diseases | |||||
Tue4 Oct03:45pm(30 mins)
|
![]() |
Dr Heulyn Jones | |||
Session : Overcoming Challenges and New Directions in Medicinal Chemistry | |||||
Room: Auditorium 2 |
TargetMol:Targets small molecules in drug discovery | |||||
Wed5 Oct02:35pm(5 mins)
|
![]() |
Ms Phoebe Feng | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors | |||||
Tue4 Oct11:10am(30 mins)
|
![]() |
Dr Jo Brewer | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
The burden of unmet needs in COPD | |||||
Tue4 Oct11:10am(30 mins)
|
![]() |
Prof Wisia Wedzicha | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
The Discovery and Clinical Efficacy of Sisunatovir | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
Dr Stuart Cockerill | |||
Session : Frontiers of chemistry applied to drug discovery | |||||
Room: Auditorium 4 |
The impact of not understanding the genetic landscape, Ignorance will cost you time and money. | |||||
Tue4 Oct04:15pm(15 mins)
|
![]() |
Melanie Maerken | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
The journey from discovery to therapy begins with a single cell | |||||
Tue4 Oct11:40am(30 mins)
|
![]() |
Stephen Hague | |||
Session : Cell & Gene Therapy Sponsored by Miltenyi | |||||
Room: Auditorium 3 |
Upgrading African disease-in-a-dish models for pharmacovigilance: Enter the humble cell | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
![]() |
Dr Janine Scholefield | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Use of human tissues to investigate drugs for the treatment of COPD | |||||
Tue4 Oct02:30pm(30 mins)
|
![]() |
Prof Luigino Calzetta | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Use of Imaging for preclinical evaluation of drugs for the treatment of COPD | |||||
Tue4 Oct12:15pm(30 mins)
|
![]() |
Dr Anna Morgan | |||
Session : Drug Discovery and Development in COPD | |||||
Room: Auditorium 4 |
Using human iPSC technology to model disease-relevant signatures of Alzheimer's disease and other tauopathies | |||||
Wed5 Oct12:35pm(15 mins)
|
![]() |
![]() |
Dr Laura Calo | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |
Utilising complex in vitro gut models in drug discovery: they needn’t be hard to stomach | |||||
Wed5 Oct12:05pm(30 mins)
|
![]() |
![]() |
Mr Nathaniel Lam | ||
Session : Developments in Preclinical Models | |||||
Room: Auditorium 1 |